Omada Health CFO sells 2,900 shares under plan

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported open-market sales of 2,900 shares of common stock on June 24–25, 2026, at weighted average prices around $19 per share.

Rhea-AI Filing Summary

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported open-market sales of 2,900 shares of common stock on June 24–25, 2026, at weighted average prices around $19 per share. The transactions were made under a pre-arranged Rule 10b5-1 trading plan. Cook directly holds 166,359 shares after these sales.

Insider Trade Summary 10b5-1

Net Seller: 2,900 shares

Net Sell 2 txns

Insider Cook Steven L.

Role Chief Financial Officer

Sold 2,900 shs ($55K)

Type	Security	Shares	Price	Value
Sale	Common Stock	300	$19.0033	$6K
Sale	Common Stock	2,600	$19.0173	$49K

Holdings After Transaction: Common Stock — 166,359 shares (Direct)

Footnotes (3)

1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
2. F2. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3. F3. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares sold total: 2,900 shares Sale price June 24: $19.0173 per share Sale price June 25: $19.0033 per share +4 more

7 metrics

Shares sold total 2,900 shares Open-market sales on June 24–25, 2026

Sale price June 24 $19.0173 per share Weighted average price for 2,600 shares sold

Sale price June 25 $19.0033 per share Weighted average price for 300 shares sold

Post-transaction holdings 166,359 shares Common stock directly held after June 25, 2026 sale

Trade plan adoption date March 14, 2026 Rule 10b5-1 trading plan adoption by CFO

Price range June 24 $19.00–$19.01 Multiple trades range for June 24, 2026 sale

Price range June 25 $19.00–$19.04 Multiple trades range for June 25, 2026 sale

Key Terms

Rule 10b5-1 trading plan, open-market sale, weighted average price, non-derivative, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action: open-market sale of common stock coded “S” as a non-derivative transaction."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

weighted average price financial

"The price reported above reflects the weighted average price for multiple trades in the stated range."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

non-derivative financial

"transaction_type is listed as non-derivative, indicating sales of common stock, not options or other derivatives."

Form 4 regulatory

"These insider transactions were disclosed in a Form 4 filed for Omada Health, Inc."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Omada Health (OMDA) report for CFO Steven L. Cook?

Omada Health reported that CFO Steven L. Cook sold 2,900 shares of common stock in open-market transactions on June 24–25, 2026, at weighted average prices near $19 per share. These transactions were disclosed in a Form 4 insider trading report.

At what prices did the Omada Health (OMDA) CFO sell his shares?

Steven L. Cook’s reported sales occurred at weighted average prices of $19.0033 and $19.0173 per share. Footnotes note multiple trades in ranges from $19.00 to $19.04 and from $19.00 to $19.01, all within a narrow band around $19.

How many Omada Health (OMDA) shares does the CFO hold after these sales?

After the reported transactions, CFO Steven L. Cook directly holds 166,359 shares of Omada Health common stock. This post-transaction holding reflects his remaining equity position as disclosed in the Form 4 following the combined sale of 2,900 shares over two trading days.

Were Omada Health (OMDA) CFO share sales made under a 10b5-1 plan?

Yes. A footnote states that the transactions were made pursuant to a Rule 10b5-1 trading plan adopted by Steven L. Cook on March 14, 2026. Such pre-arranged plans are established in advance to execute trades according to predetermined instructions.

What is the nature of the Omada Health (OMDA) CFO’s reported share sales?

The Form 4 characterizes both transactions as open-market sales of common stock, coded “S.” They are non-derivative transactions, meaning actual shares, not options or other derivatives, were sold. Ownership is reported as direct, with no derivative positions listed in the filing’s derivative summary.

How many Omada Health (OMDA) shares did the CFO sell on each day?

Steven L. Cook sold 2,600 shares of common stock on June 24, 2026, at a weighted average price of $19.0173 per share, and 300 shares on June 25, 2026, at a weighted average price of $19.0033 per share, according to the Form 4 details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 07:03 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cook Steven L.

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2026		S(1)		2,600	D	$19.0173(2)	166,659	D
Common Stock	06/25/2026		S(1)		300	D	$19.0033(3)	166,359	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

2. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Nathan Salha, as Attorney-in-Fact for Steven L. Cook	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)